Multiple Sclerosis Treatment - FOI Response Register

FoI Number
2025-108
Subject
Multiple Sclerosis Treatment
Date Received
15/05/2025
Request and Response
  1. How many patients has your trust treated in the past six months (for any disease) with the following drugs:

Drug Name

Patient Number

Aubagio (teriflunomide)

 

Avonex (interferon beta-1a)

 

Betaferon (interferon beta-1b)

 

Brabio (glatiramer acetate)

 <5

Copaxone (glatiramer acetate)

 

Extavia (beta interferon-1b)

 

Gilenya (fingolimod)

 

Kesimpta (ofatumumab)

 5

Lemtrada (alemtuzumab)

 

Mavenclad (cladribine)

 

Mayzent (siponimod)

 

Ocrevus (ocrelizumab)

 <5

Plegridy (peginterferon beta-1a)

 

Ponvory (ponesimod)

 

Rebif (beta interferon-1a)

 <5

Tecfidera (dimethyl fumarate)

 <5

Tysabri (natalizumab)

 

Tysabri (natalizumab) Pre-filled syringes only

 

Vumerity (diroximel fumarate)

 

Zeposia (ozanimod)

 

Fingolimod generic

 <5

Tyruko (Natalizumab Biosimilar)

 

 

 

  

Where we have given <5 answers, this is because NHS Shetland considers that providing more specific information carries a high risk of identifying individuals. As such and in accordance with FOISA s 16(1), NHS Shetland confirms that it holds the information requested but that it is exempt from disclosure under FOISA s 38(1)(b) as read with s 38 (2A) as the information constitutes personal data and disclosure would breach the confidentiality of the data subjects

  1. How many patients has you trust treated with Rituximab for MS (Multiple Sclerosis) in the past six months? 

In accordance with FOISA s 17(1), NHS Shetland confirms that it does not hold the information requested. NHS Shetland does not hold condition linked prescribing data.

  1. How many patients within your trust have a diagnosis of MS (Multiple Sclerosis)?

100 patients

  1. Of the patients with a diagnosis of Multiple Sclerosis, how many patients have a diagnosis of:

Condition

Patient Number

RRMS – Relapse Remitting Multiple Sclerosis

 

PPMS – Primary Progressive Multiple Sclerosis

 

SPMS – Secondary Progressive Multiple Sclerosis

 

In accordance with FOISA s 17(1), NHS Shetland confirms that it does not hold the information requested.